Stock Analysis on Net

Eli Lilly & Co. (NYSE:LLY)

Statement of Comprehensive Income 

Eli Lilly & Co., consolidated statement of comprehensive income

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income 5,240,400 6,244,800 5,581,700 6,193,700 8,318,400
Change in foreign currency translation gains (losses) 55,200 (324,000) (122,700) 250,400 (108,300)
Change in net unrealized gains (losses) on available-for-sale securities 10,900 (40,800) (11,100) 9,900 27,000
Change in retirement benefit plans (635,000) 521,300 2,167,400 (112,300) (785,900)
Change in net unrealized gains (losses) on cash flow hedges 86,500 342,000 119,700 (120,800) 27,000
Other comprehensive income (loss) from continuing operations, net of tax (482,400) 498,500 2,153,300 27,200 (840,200)
Other comprehensive income from discontinued operations, net of tax 56,800
Other comprehensive income (loss), net of tax (482,400) 498,500 2,153,300 27,200 (783,400)
Comprehensive income 4,758,000 6,743,300 7,735,000 6,220,900 7,535,000

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Comprehensive income item Description The company
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Eli Lilly & Co. net income increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Comprehensive income Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Eli Lilly & Co. comprehensive income decreased from 2021 to 2022 and from 2022 to 2023.